According to AstraZeneca's latest financial reports the company's current revenue (TTM) is $44.35 B. In 2021 the company made a revenue of $37.41 B an increase over the years 2020 revenue that were of $26.61 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $44.35 B | 18.53% |
2021 | $37.41 B | 40.58% |
2020 | $26.61 B | 9.16% |
2019 | $24.38 B | 10.38% |
2018 | $22.09 B | -1.67% |
2017 | $22.46 B | -2.33% |
2016 | $23.00 B | -6.9% |
2015 | $24.70 B | -5.32% |
2014 | $26.09 B | 1.49% |
2013 | $25.71 B | -8.09% |
2012 | $27.97 B | -16.72% |
2011 | $33.59 B | 0.97% |
2010 | $33.26 B | 1.42% |
2009 | $32.80 B | 3.81% |
2008 | $31.60 B | 6.91% |
2007 | $29.55 B | 11.65% |
2006 | $26.47 B | 10.54% |
2005 | $23.95 B | 11.78% |
2004 | $21.42 B | 13.67% |
2003 | $18.84 B | 6.33% |
2002 | $17.72 B | -24.67% |
2001 | $23.53 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $94.94 B | 114.08% | ๐บ๐ธ USA |
![]() Novartis NVS | $51.82 B | 16.86% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $100.33 B | 126.23% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $43.65 B | -1.57% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $28.54 B | -35.65% | ๐บ๐ธ USA |
![]() Sanofi SNY | $47.62 B | 7.39% | ๐ซ๐ท France |
![]() Biogen BIIB | $10.17 B | -77.06% | ๐บ๐ธ USA |
![]() Merck MRK | $59.28 B | 33.67% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $46.15 B | 4.08% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $38.94 B | -12.20% | ๐ฌ๐ง UK |